![](https://investorshub.advfn.com/uicon/491452.png?cb=1557872961)
Tuesday, November 06, 2018 7:52:10 AM
RecoveryRx is what was entered.
IMO it doesn't match up well with the criteria given (see link).
https://www.fda.gov/aboutfda/centersoffices/officeofmedicalproductsandtobacco/cdrh/cdrhinnovation/ucm609082.htm
RR is a post-surgical device. I just don't think it's what they are looking for in the challenge. Seems much more about end-user devices/products, and nothing at all related to post-op. I'll happily be wrong if it does get accepted. I will put the odds at 15% right now.
The company had said they were working on and going to submit a 510k on rr, and then did a bait and switch (IMO) and entered the challenge instead. If it's not accepted, who knows if they will end up doing one or not. They obviously should, and shoulda coulda woulda been done years ago at this point.
They should be notified by end of the month on if they got accepted or not, and give an update regardless. JMHO but they aren't known to be the best communicators. gl
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM